CKD-828 (80/5mg) Pharmacokinetic Study

NCT02250833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: CKD-828
DRUG: Telmisartan
DRUG: S-amlodipine

Sponsor

Chong Kun Dang Pharmaceutical